# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001802768-22-000011
Filing Date
2022-02-15
Accepted
2022-02-15 09:03:34
Documents
91
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | rprx-20211231.htm iXBRL | 10-K | 3476830
2 | EX-4.2 | rprx-20211231ex42.htm | EX-4.2 | 40856
3 | EX-23.1 | rprx-20211231ex231.htm | EX-23.1 | 3755
4 | EX-31.1 | rprx-20211231ex311.htm | EX-31.1 | 9292
5 | EX-31.2 | rprx-20211231ex312.htm | EX-31.2 | 9310
6 | EX-32 | rprx-20211231ex32.htm | EX-32 | 5136
12 |  | rprx-20211231_g1.jpg | GRAPHIC | 121186
13 |  | rprx-20211231_g2.jpg | GRAPHIC | 116987
14 |  | rprx-20211231_g3.jpg | GRAPHIC | 130531
15 |  | rprx-20211231_g4.jpg | GRAPHIC | 131677
| Complete submission text file | 0001802768-22-000011.txt |  | 14537339

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rprx-20211231.xsd | EX-101.SCH | 85411
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rprx-20211231_cal.xml | EX-101.CAL | 101991
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rprx-20211231_def.xml | EX-101.DEF | 540017
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rprx-20211231_lab.xml | EX-101.LAB | 925560
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rprx-20211231_pre.xml | EX-101.PRE | 663728
85 | EXTRACTED XBRL INSTANCE DOCUMENT | rprx-20211231_htm.xml | XML | 2336261

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39329 | Film No.: 22637203
SIC: 2834 Pharmaceutical Preparations